India is to make barcoding mandatory on all medicines sold within the country after a recent report by the Office of the US Trade Representative (USTR) identified the country as the largest producer of counterfeit pharmaceuticals in the world.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
25 April 2019 The Delhi High Court has cleared two Indian drug companies to export a cancer drug and blood thinner, both patented by Bayer, for the purposes of development and clinical trials for regulatory clearances.
25 April 2019 The Delhi High Court has cleared two Indian drug companies to export a cancer drug and blood thinner, both patented by Bayer, for the purposes of development and clinical trials for regulatory clearances.
25 April 2019 The Delhi High Court has cleared two Indian drug companies to export a cancer drug and blood thinner, both patented by Bayer, for the purposes of development and clinical trials for regulatory clearances.